Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112655173 | 11265517 | 3 | F | 20160713 | 20150713 | 20160728 | EXP | US-JNJFOC-20150705391 | JOHNSON AND JOHNSON | 0.00 | A | M | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112655173 | 11265517 | 1 | PS | TYLENOL | ACETAMINOPHEN | 1 | Oral | Y | N | 19872 | UNSPECIFIED | ||||||||
| 112655173 | 11265517 | 2 | SS | TYLENOL | ACETAMINOPHEN | 1 | Oral | Y | N | 19872 | 1000 | MG | UNSPECIFIED | ||||||
| 112655173 | 11265517 | 3 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 25 | MG | TABLETS | ||||||
| 112655173 | 11265517 | 4 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 500 | MG | TABLETS | BID | |||||
| 112655173 | 11265517 | 5 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 25 | MG | TABLETS | ||||||
| 112655173 | 11265517 | 6 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 25 | MG | TABLETS | ||||||
| 112655173 | 11265517 | 7 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 100 | MG | TABLETS | ||||||
| 112655173 | 11265517 | 8 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 300 | MG | TABLETS | QD | |||||
| 112655173 | 11265517 | 9 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 550 | MG | TABLETS | QD | |||||
| 112655173 | 11265517 | 10 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 500 | MG | TABLETS | BID | |||||
| 112655173 | 11265517 | 11 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 25 | MG | TABLETS | ||||||
| 112655173 | 11265517 | 12 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 550 | MG | TABLETS | QD | |||||
| 112655173 | 11265517 | 13 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 300 | MG | TABLETS | QD | |||||
| 112655173 | 11265517 | 14 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 25 | MG | TABLETS | ||||||
| 112655173 | 11265517 | 15 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 100 | MG | TABLETS | ||||||
| 112655173 | 11265517 | 16 | I | LAMICTAL | LAMOTRIGINE | 1 | Oral | U | UNK | 0 | 25 | MG | TABLETS | ||||||
| 112655173 | 11265517 | 17 | SS | TYLENOL PM | ACETAMINOPHENDIPHENHYDRAMINE | 1 | Oral | U | U | 999999 | UNSPECIFIED | ||||||||
| 112655173 | 11265517 | 18 | C | KLONOPIN | CLONAZEPAM | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112655173 | 11265517 | 2 | Sleep disorder |
| 112655173 | 11265517 | 3 | Seizure |
| 112655173 | 11265517 | 4 | Seizure |
| 112655173 | 11265517 | 5 | Seizure |
| 112655173 | 11265517 | 6 | Seizure |
| 112655173 | 11265517 | 7 | Seizure |
| 112655173 | 11265517 | 8 | Seizure |
| 112655173 | 11265517 | 9 | Seizure |
| 112655173 | 11265517 | 10 | Temporal lobe epilepsy |
| 112655173 | 11265517 | 11 | Temporal lobe epilepsy |
| 112655173 | 11265517 | 12 | Temporal lobe epilepsy |
| 112655173 | 11265517 | 13 | Temporal lobe epilepsy |
| 112655173 | 11265517 | 14 | Temporal lobe epilepsy |
| 112655173 | 11265517 | 15 | Temporal lobe epilepsy |
| 112655173 | 11265517 | 16 | Temporal lobe epilepsy |
| 112655173 | 11265517 | 17 | Sleep disorder |
| 112655173 | 11265517 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112655173 | 11265517 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112655173 | 11265517 | Drug interaction | |
| 112655173 | 11265517 | Off label use | |
| 112655173 | 11265517 | Product use issue | |
| 112655173 | 11265517 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112655173 | 11265517 | 2 | 200408 | 0 | ||
| 112655173 | 11265517 | 4 | 199604 | 0 | ||
| 112655173 | 11265517 | 5 | 2014 | 0 | ||
| 112655173 | 11265517 | 6 | 20080425 | 0 | ||
| 112655173 | 11265517 | 10 | 199604 | 0 | ||
| 112655173 | 11265517 | 11 | 20080425 | 0 | ||
| 112655173 | 11265517 | 16 | 2014 | 0 | ||
| 112655173 | 11265517 | 17 | 2004 | 201305 | 0 |